F7 Alternative Models for Early Commercialization of Academic Life Sciences Research
Track: Startups and Gap Funding
Target Audience: All Audiences
Atul Varadhachary, Fannin Innovation Studio
In this session, we’ll present lessons learned from alternative models for commercializing life sciences research. University of Texas M.D. Anderson Cancer Center will share how they catalyzed a wave of commercialization outcomes ranging from startups and joint ventures to straight licenses and strategic, multiasset collaborations. Houston Methodist Research Institute will discus their investment in building and staffing state-of-the-art cGMP manufacturing and GLP toxicity facilities to overcome the high cost of current good manufacturing practice (cGMP) manufacture and good laboratory practice (GLP) toxicity studies. Texas Children’s Hospital and Baylor College of Medicine will describe their three-pronged attack to overcome the high cost of traditional medical device development: leveraging hospital consortium to identify unmet needs and commit funding; partnering with engineering schools to develop prototypes; and leveraging pooled management team to spread out costs. Fannin Innovation Studio partnered with institutions to spin out science and technologies while keeping academic investigators actively engaged.
Return to Schedule